You are here: Home / Cancer Research Network / Dr Glen Reid / Dr Glen Reid 

Dr Glen Reid

Senior Lecturer of the ADRI
Asbestos Diseases Research Institute, Concord Clinical School

Asbestos Diseases Research Institute
The University of Sydney
NSW 2006 Australia

T: +61 2 9767 9800
F: +61 2 9767 9860
E:

Research interests

As Senior Research Scientist at the Asbestos Diseases Research Insitute I lead research focused on translational studies of malignant pleural mesothelioma, an asbestos-related cancer for which Australia has one of the world’s highest incidence rates. My research aims to identify new molecular biomarkers and novel therapeutic targets for this disease.

Back to Top

Current national competitive grants*

2012

The use of RNAi to identify new therapeutic targets for malignant mesothelioma
Reid G
Cancer Australia Priority-driven Collaborative Cancer Research Scheme ($374,229 over 3 years)

* Grants administered through the University of Sydney

Back to Top

Keywords

Asbestos-related diseases; Cancer; Molecular biology; Malignant mesothelioma

Back to Top

Publications

2012 | 2011 | 2010

2012

   
  • Kirschner, M., Cheng, Y., Badrian, B., Kao, S., Creaney, J., Edelman, J., Armstrong, N., Vallely, M., Musk, A., Robinson, B., McCaughan, B., Klebe, S., Mutsaers, S., van Zandwijk, N., Reid, G. (2012), Increased Circulating miR-625-3p: A Potential Biomarker for Patients With Malignant Pleural Mesothelioma. Journal of Thoracic Oncology. 7(7), 1184-1191. [Abstract]
  • Lasham, A., Samuel, W., Cao, H., Patel, R., Mehta, R., Stern, J., Reid, G., Woolley, A., Miller, L., Black, M., Shelling, A., Print, C., Braithwaite, A. (2012), YB-1, the E2F Pathway, and Regulation of Tumor Cell Growth. Journal of the National Cancer Institute. 104(2), 133-46. [Abstract]

2011

   
Back to Top
  • Kao, S., Klebe, S., Henderson, D., Reid, G., Chatfield, M., Armstrong, N., Yan, T., Vardy, J., Clarke, S., van Zandwijk, N., McCaughan, B. (2011), Low Calretinin Expression and High Neutrophil-To-Lymphocyte Ratio Are Poor Prognostic Factors in Patients with Malignant Mesothelioma Undergoing Extrapleural Pneumonectomy. Journal of Thoracic Oncology. 6(11), 1923-1929. [Abstract]
  • Reid, G., Kirschner, M., van Zandwijk, N. (2011), Circulating microRNAs: Association with disease and potential use as biomarkers. Critical reviews in oncology/hematology. 80(2), 193-208. [Abstract]
  • Li, Y., Revalde, J., Reid, G., Paxton, J. (2011), Modulatory effects of curcumin on multi-drug resistance-associated protein 5 in pancreatic cancer cells. Cancer chemotherapy and pharmacology. 68(0), 603-10. [Abstract]
  • Kao, S., Reid, G., van Zandwijk, N., Henderson, D., Klebe, S. (2011), Molecular biomarkers in malignant mesothelioma: state of the art. Pathology. 43(3), 201-112. [Abstract]
  • Kao, S., Lee, K., Armstrong, N., Clarke, S., Vardy, J., van Zandwijk, N., Reid, G., Burn, J., McCaughan, B., Henderson, D., Klebe, S. (2011), Validation of tissue microarray technology in malignant pleural mesothelioma. Pathology. 43(2), 128-132. [Abstract]
  • Herbert, M., Coppieters, N., Lasham, A., Cao, H., Reid, G. (2011), The importance of RT-qPCR primer design for the detection of siRNA-mediated mRNA silencing. BMC research notes. 4(1), 148. [Abstract]
  • Kirschner, M., Kao, S., Edelman, J., Armstrong, N., Vallely, M., van Zandwijk, N., Reid, G. (2011), Haemolysis during Sample Preparation Alters microRNA Content of Plasma. PloS One. 6(9), e24145. [Abstract]

2010

   
Back to Top
  • Li, Y., Revalde, J., Reid, G., Paxton, J. (2010), Interactions of dietary phytochemicals with ABC transporters: possible implications for drug disposition and multidrug resistance in cancer. Drug Metabolism Reviews. 42(4), 590-611. [Abstract]
  • Kao, S., Reid, G., Lee, K., Vardy, J., Clarke, S., van Zandwijk, N. (2010), Malignant Mesothelioma. Internal Medicine Journal. 40(11), 742-750. [Abstract]
  • Lasham, A., Herbert, M., Coppieters 't Wallant, N., Patel, R., Feng, S., Eszes, M., Cao, H., Reid, G. (2010), A rapid and sensitive method to detect siRNA-mediated mRNA cleavage in vivo using 5' RACE and a molecular beacon probe. Nucleic Acids Research. 38(3), e19. [Abstract]